+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

Rosacea - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Rosacea - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
From
Palmar Hyperhidrosis - Epidemiology Forecast to 2032 (US) - Product Thumbnail Image

Palmar Hyperhidrosis - Epidemiology Forecast to 2032 (US)

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Chronic Spontaneous Urticaria (CSU) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chronic Spontaneous Urticaria (CSU) - Epidemiology Forecast - 2032

  • Drug Pipelines
  • January 2022
  • 100 Pages
  • Global
From
Contact Dermatitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Contact Dermatitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Inducible Urticaria Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Inducible Urticaria Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Athlete's Foot (Tinea Pedis) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Athlete's Foot (Tinea Pedis) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Prurigo Nodularis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Prurigo Nodularis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Radiation Dermatitis - Epidemiology Insight - 2032 - Product Thumbnail Image

Radiation Dermatitis - Epidemiology Insight - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Infliximab-Biosimilars Insight, 2022 - Product Thumbnail Image

Infliximab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Adalimumab-Biosimilars Insight, 2022 - Product Thumbnail Image

Adalimumab-Biosimilars Insight, 2022

  • Report
  • January 2022
  • 90 Pages
  • Global
From
Netherton Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Netherton Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
LY3454738 - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

LY3454738 - Emerging Insight and Market Forecast - 2030

  • Report
  • February 2021
  • 35 Pages
  • Global
From
FENEBRUTINIB - Emerging Insight and Market Forecast - 2030 - Product Thumbnail Image

FENEBRUTINIB - Emerging Insight and Market Forecast - 2030

  • Report
  • December 2020
  • 60 Pages
  • Global
From
Tremfya - Drug Insight, 2019 - Product Thumbnail Image

Tremfya - Drug Insight, 2019

  • Report
  • July 2019
  • Global
From
Pruritus Drugs Market Report and Forecast 2024-2032 - Product Thumbnail Image

Pruritus Drugs Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 200 Pages
  • Global
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more